脑电引导麻醉管理对老年大手术后谵妄的影响:ENGAGES随机临床试验
ENGAGES随机临床试验在Barnes-Jewish医院纳入1232例60岁及以上接受大手术并全身麻醉的成人,1:1随机分为脑电引导麻醉管理组(n=614)或常规麻醉组(n=618)。主要终点为术后第1至5天发生的谵妄,引导组157/604例(26.0%),常规组140/609例(23.0%),差异3.0%(95%CI -2.0%至8.0%),P=0.22。引导组中位呼气末挥发性麻醉药浓度显著更低(0.69 vs 0.80 MAC),中位脑电抑制累计时间显著更短(7 vs 13分钟),但两组平均动脉压低于60 mmHg的累计时间无显著差异。结论:脑电引导麻醉管理未降低老年大手术后谵妄发生率,该发现不支持为此适应症使用脑电引导麻醉管理。
要点
- 在60岁及以上大手术老年患者中,脑电引导麻醉管理组术后第1至5天谵妄发生率为26.0%(157/604),常规麻醉组为23.0%(140/609),差异3.0%(95%CI -2.0%至8.0%),P=0.22,未达统计学显著。
- 脑电引导组中位呼气末挥发性麻醉药浓度为0.69 MAC,显著低于常规组的0.80 MAC,差异-0.11(95%CI -0.13至-0.10)。
- 脑电引导组中位脑电抑制累计时间为7分钟,显著少于常规组的13分钟,差异-6.0(95%CI -9.9至-2.1)。
- 两组中位平均动脉压低于60 mmHg的累计时间无显著差异(7 vs 7分钟;差异0.0,95%CI -1.7至1.7)。
- 脑电引导组不自主体动发生率为22.3%(137例),高于常规组的15.4%(95例);两组均无患者报告术中知晓。
适用人群与场景
- 年龄60岁及以上(中位年龄69岁,范围60至95岁),接受大手术并全身麻醉的成人。
- 招募地点为圣路易斯Barnes-Jewish医院,招募时间2015年1月至2018年5月,随访至2018年7月。
诊断标准与关键阈值
- 主要终点为术后第1至5天发生的谵妄。
处置流程与药物剂量
- 脑电引导麻醉管理组:根据脑电监测调整麻醉药给药,中位呼气末挥发性麻醉药浓度为0.69 MAC,中位脑电抑制累计时间7分钟。
- 常规麻醉组:常规麻醉管理,中位呼气末挥发性麻醉药浓度为0.80 MAC,中位脑电抑制累计时间13分钟。
研究设计与关键结果
- 随机对照试验,1232例患者1:1随机分为脑电引导麻醉管理组(n=614)或常规麻醉组(n=618),按心脏与非心脏手术、近期跌倒史阳性与阴性分层。
- 1213例(98.5%)完成主要终点评估;脑电引导组术后第1至5天谵妄157/604例(26.0%),常规组140/609例(23.0%),差异3.0%(95%CI -2.0%至8.0%),P=0.22。
- 脑电引导组中位呼气末挥发性麻醉药浓度0.69 MAC vs 常规组0.80 MAC,差异-0.11(95%CI -0.13至-0.10)。
- 脑电引导组中位脑电抑制累计时间7分钟 vs 常规组13分钟,差异-6.0(95%CI -9.9至-2.1)。
- 两组中位平均动脉压低于60 mmHg的累计时间无显著差异:7 vs 7分钟,差异0.0(95%CI -1.7至1.7)。
- 不自主体动:脑电引导组137例(22.3%) vs 常规组95例(15.4%);术中知晓伴回忆:无患者报告。
- 术后恶心呕吐:脑电引导组48例(7.8%) vs 常规组55例(8.9%);严重不良事件:脑电引导组124例(20.2%) vs 常规组130例(21.0%)。
- 术后30天内死亡:脑电引导组4例(0.65%) vs 常规组19例(3.07%)。
证据类型、等级与局限
- 证据类型:随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,该发现不支持为此适应症(降低老年大手术后谵妄发生率)使用脑电引导麻醉管理。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: Intraoperative electroencephalogram (EEG) waveform suppression, often suggesting excessive general anesthesia, has been associated with postoperative delirium.
OBJECTIVE: To assess whether EEG-guided anesthetic administration decreases the incidence of postoperative delirium.
DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial of 1232 adults aged 60 years and older undergoing major surgery and receiving general anesthesia at Barnes-Jewish Hospital in St Louis. Recruitment was from January 2015 to May 2018, with follow-up until July 2018.
INTERVENTIONS: Patients were randomized 1:1 (stratified by cardiac vs noncardiac surgery and positive vs negative recent fall history) to receive EEG-guided anesthetic administration (n = 614) or usual anesthetic care (n = 618).
MAIN OUTCOMES AND MEASURES: The primary outcome was incident delirium during postoperative days 1 through 5. Intraoperative measures included anesthetic concentration, EEG suppression, and hypotension. Adverse events included undesirable intraoperative movement, intraoperative awareness with recall, postoperative nausea and vomiting, medical complications, and death.
RESULTS: Of the 1232 randomized patients (median age, 69 years [range, 60 to 95]; 563 women [45.7%]), 1213 (98.5%) were assessed for the primary outcome. Delirium during postoperative days 1 to 5 occurred in 157 of 604 patients (26.0%) in the guided group and 140 of 609 patients (23.0%) in the usual care group (difference, 3.0% [95% CI, -2.0% to 8.0%]; P = .22). Median end-tidal volatile anesthetic concentration was significantly lower in the guided group than the usual care group (0.69 vs 0.80 minimum alveolar concentration; difference, -0.11 [95% CI, -0.13 to -0.10), and median cumulative time with EEG suppression was significantly less (7 vs 13 minutes; difference, -6.0 [95% CI, -9.9 to -2.1]). There was no significant difference between groups in the median cumulative time with mean arterial pressure below 60 mm Hg (7 vs 7 minutes; difference, 0.0 [95% CI, -1.7 to 1.7]). Undesirable movement occurred in 137 patients (22.3%) in the guided and 95 (15.4%) in the usual care group. No patients reported intraoperative awareness. Postoperative nausea and vomiting was reported in 48 patients (7.8%) in the guided and 55 patients (8.9%) in the usual care group. Serious adverse events were reported in 124 patients (20.2%) in the guided and 130 (21.0%) in the usual care group. Within 30 days of surgery, 4 patients (0.65%) in the guided group and 19 (3.07%) in the usual care group died.
CONCLUSIONS AND RELEVANCE: Among older adults undergoing major surgery, EEG-guided anesthetic administration, compared with usual care, did not decrease the incidence of postoperative delirium. This finding does not support the use of EEG-guided anesthetic administration for this indication.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02241655.
参考来源
- Wildes TS, Mickle AM, Ben Abdallah A, et al. Effect of Electroencephalography-Guided Anesthetic Administration on Postoperative Delirium Among Older Adults Undergoing Major Surgery: The ENGAGES Randomized Clinical Trial. JAMA. 2019. PMID: 30721296. doi:10.1001/jama.2018.22005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。